Use of recombinant factor VIIa (rFVIIa) in the management of intractable haemorrhage: a survey of current UK practice

Br J Haematol. 2007 Jul;138(1):126-8. doi: 10.1111/j.1365-2141.2007.06621.x.
No abstract available

Publication types

  • Letter

MeSH terms

  • Drug Administration Schedule
  • Factor VII / therapeutic use*
  • Factor VIIa
  • Hematology*
  • Hemorrhage / drug therapy*
  • Humans
  • Practice Patterns, Physicians'*
  • Recombinant Proteins / therapeutic use
  • United Kingdom

Substances

  • Recombinant Proteins
  • Factor VII
  • recombinant FVIIa
  • Factor VIIa